期刊文献+

不同类型干扰素对Toll样受体在Huh7细胞中表达的影响 被引量:1

The impact of different types of interferon on the expression of Toll-like receptors in Huh7 cells
原文传递
导出
摘要 目的探讨不同类型干扰素对肝细胞Toll样受体(toll like receptor,TLR)3、4、7、9表达的影响。方法感染丙型肝炎病毒(hepatitis C virus,HCV)JFH-1病毒的Huh7细胞分别加入干扰素α(interferon,IFN-α)、IFN-β、IFN-γ、IFN-λ1处理24 h,以实时定量聚合酶链反应(real time polymerase chain reaction,RT-PCR)分析Toll样受体3、4、7、9以及HCV复制水平的变化。结果各干扰素均能抑制HCV的复制(t分别为-45.699、-68.165、-70.994、-67.111,均有P<0.001)。方差分析显示各干扰素处理组间TLR3、TLR4、TLR7及TLR9的相对表达量差异有统计学意义(F分别为125.901、263.537、163.289、31.774,均有P<0.001),进一步两两比较可知,IFN-α、IFN-β能上调TLR3(t分别为21.312、25.420,均有P<0.001)、TLR7(t分别为26.456、24.289,均有P<0.001)的表达,同时下调TLR9的表达,而对TLR4的表达没有影响;IFN-γ可上调TLR4、TLR7的表达,对TLR3和TLR9的表达没有影响;IFN-λ1可上调TLR3、TLR7、TLR9的表达水平,但对TLR4的表达没有影响。结论不同干扰素对肝细胞不同Toll样受体表达的作用不同,反映出不同干扰素具有不同的抗病毒作用机制。 Objective To investigate the effects of different types of interferon on the expression of TLR3 ,TLR4,TLR7 and TLR9 in. human hepatocytes. Methods HCV JFH-l-infected Huh7 cells were treated by IFN-α, IFN-β, IFN-γ, IFN-λ1 respectively for 24 h. The expression of TLR3, TLR4, TLR7 and TLR9 of Huh7 cells and the levels of HCV RNA were determined by real time PCR. Results All interferons (IFN-α, IFN-β, IFN-γ, IFN-λ1 ) could significantly inhibit HCV replication in Huh7 ceils (t = - 45. 699, - 68. 165, - 70. 994, - 67.111 respectively, all P 〈 0. 001 ). The ANOVA showed that the levels of TLR3, TLR4, TLR7 and TLR9 expression among different IFN - treated groups had significant difference ( F = 125.901,263. 537,163. 289,31. 774 respectively, all P 〈0. 001 ), and comparisons between two groups showed that IIFN-α and IFN-β treatments significantly increased the expression of TLR3, TLR7 (t = 21. 312, 25.420, 26. 456, 24. 289, all P 〈 0. 001 ), and decreased the expression of TLR9, but had no significant effect on the expression of TLR4. IFN-γ treatment significantly increased the expression of TLR4 and TLR7, but had no significant effect on the expression of TLR3 and TLR9. IFN-λ1 treatment increased the expression of TLR3, TLR7 and TLR9, but had no significant influence on the expression of TLR4. Conclusions Different types of interferon have different effects on TLR expression pattern in human hepatocytes, implying that antiviral mechanisms vary with the types of interferons used against HCV infection in hepatocytes.
出处 《中华疾病控制杂志》 CAS 北大核心 2014年第6期477-480,共4页 Chinese Journal of Disease Control & Prevention
基金 国家自然科学基金(81271851) 广西自然科学基金(2013GXNSFCB019004) 2013年度广西高校科学技术研究(2013YB041)
关键词 干扰素 丙型肝炎病毒 TOLL样受体 Interferon Hepatitis C virus Toll like receptor
  • 相关文献

参考文献17

  • 1Tabeta K, George! P, Janssen E, et al. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection [ J ]. Proc Natl Acad Sci U S A, 2004, 101 (10) :3516-3521.
  • 2徐娟,黄俊琪.Toll样受体3相关信号转导途径与病毒感染[J].热带医学杂志,2009,9(1):104-107. 被引量:4
  • 3Ayres JS, Vance RE. Cellular teamwork in antibacterial innate im- munity [J]. Nat Immunol, 2012,13(2) :115-117.
  • 4Hunyady B, Kov6cs B, Batty6ni Z. Side-effects of pegylated inter- feron plus ribavirin therapy with or without protease inhibitor direct acting antiviral agents during treatment of chronic hepatitis C virus infection [ J ]. Orv Hetil, 2011,152 (50) : 1997-2009.
  • 5卢年芳,黄爱龙.干扰素抗病毒作用的机制[J].国外医学(流行病学.传染病学分册),2003,30(4):226-228. 被引量:18
  • 6K-atja Derkow, Jakob MJ Bauer, Michael Hecker, et al. Muhiple Sclerosis: Modulation of Toll-Like Receptor (TLR) Expression by Interferon-13 Includes Upregulation of TLR7 in Plasmacytoid Den- dritic Cells [J]. PLoS One, 2013, 8(8) : e70626.
  • 7CM. P. Telaprevir: a review of its use in the management of geno- type 1 chronic hepatitis C [J]. Drugs, 2012,72(5) : 619-641.
  • 8Garnock-Jones KP. Boceprevir: a review of its use in the manage- ment of chronic hepatitis C genotype 1 infection [ J ]. Drugs, 2012,72( 18 ) : 2431-2456.
  • 9Meyer O. Interferons and autoimmune disorders [ J ]. Joint Bone Spine, 2009,76(5 ) :464-473.
  • 10杨莉萍,曹素艳,邵宏.干扰素的抗病毒作用及其临床应用[J].国外医学(药学分册),2004,31(2):78-82. 被引量:10

二级参考文献100

  • 1Medzhitov R, Preston-Hurlburt P, Janeway CA Jr.A human homologue of the Drosophila Toll protein signals activation of adaptive immunity [J]. Nature, 1997,388(6640) :394-397.
  • 2Alexopoulou L, Holt AC, Medzhitov R, et al. Recognition of double-stranded RNA and activation of NF-kappaB by Toillike receptor 3 [ J ]. Nature, 2001,413 (6857) : 732-738.
  • 3Sankar S, Chan H, Romanow WJ, et al. IKK-i signals through IRF3 and NFkappaB to mediate the production of inflammatory cytokines[ J ]. Cell Signal, 2006,18 (7) : 982-993.
  • 4Hacker H, Redecke V, Blagoev B, et al. Specificity in Toll- like receptor signalling through distinct effector functions of TRAF3 and TRAF6 [ J ]. Nature, 2006,439 (7073) : 204-207.
  • 5Uematsu S, Sato S, Yamamoto M, et al. Interleukin-1 receptor-associated kinase-1 plays an essential role for Tolllike receptor (TLR)7- and TLR9-mediated interferon-talphal induction[J]. J Exp Med, 2005,201 (6) :915-923.
  • 6Takaoka A, Yanai H, Kondo S, et al. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors [ J ]. Nature, 2005,434 (7030) : 243-249.
  • 7Gohda J, Matsumura T, Inoue J. Cutting edge: TNFR- associated factor (TRAF) 6 is essential for MyD88-dependent pathway but not toll/IL-1 receptor domain-containing adaptorinducing IFN-beta (TRIF)-dependem pathway in TLR signaling[J]. J Immuno],2004,173(5) :2913-2917.
  • 8Meylan E, Burns K, Hofmann K, et al. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation [ J ]. Nat Immunol, 2004,5 (5) : 503-507.
  • 9Cusson-Hermance N, Khurana S, Lee TH, et al. Ripl mediates the Trif-dependent toll-like receptor 3- and 4- induced NF-tkappat B activation but does not contribute to interferon regulatory factor 3 activation [J]. J Biol Chem, 2005,280 (44) : 36560-36566.
  • 10Sarkar SN, Peters KL, Elco CP, et al. Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling [ J ]. Nat Struet Mol Biol, 2004,11 ( 11 ) :1060-1067.

共引文献29

同被引文献15

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部